Robotic assisted versus laparoscopic surgery for deep endometriosis: a meta-analysis of current evidence

Data collection included: author, publication year, country, sample size, age, BMI, rASRM [ 12 ], stage previous surgery, intra- and postoperative reported data. We will provide our data for independent analysis by a selected team or for additional data analysis or for the reproducibility of this study in other centers if such is requested.

Rayyan software (Qatar Computing Research Institute, HBKU, Doha, Qatar) [ 11 ] was used independently by two authors (MP and AB) to screen titles and abstracts for eligibility. Manual searches were performed on pertinent resources and online links, and references of selected articles were examined. Duplicate entries were eliminated during the title/abstract review. For all relevant studies, the complete text was reviewed by both authors independently. Discordant assessments were resolved by consultation of a third author (MG).

The studies included for analysis were obtained querying the PubMed database, Google Scholar and ClinicalTrial.gov between September and November 2023, filtered only by English language and publication year (1980–2023). The search strategy is reported in the supplementary material (Online Supplementary A).

The review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [ 10 ]. Before data extraction, the review was registered with the International Prospective Register of Systematic Reviews (PROSPERO, Registration N° CRD CRD42023495700).

The initial search identified 340 articles. After removing duplicates and title/abstract screening, 79 manuscripts were assessed for eligibility. Of these, were excluded as they addressed a different outcome (51) or a different design (10) or were inaccessible (2) or in a language different than English (1). A list of excluded articles is provided in Online Supplementary B. Consequently, fourteen studies were included for data synthesis (Online Supplementary C) and one prospective trial was identified. The PRISMA flow diagram shows the complete review process from the original search to the final selection (Fig.  1 ). The Fourteen studies selected for the meta-analysis covered a total of 2709 patients. Of these twelve (85.7%) are retrospective and 2 prospective (14.3%). Fig. 1 PRISMA Flow diagram for study selection PRISMA Flow diagram for study selection The quality assessment of the included studies is presented in Online Supplementary D. Most studies were at low risk of bias regarding patient selection, index test, and reference standard domains (8, 61,5%). Five articles had an unclear risk of bias in the patient’s selection as they reported data on patients without differentiating the rASRM stage [ 5 , 14 – 17 ] while one focused only on stage IV [ 18 ]. One was at an unclear risk of bias and applicability in patient selection due to the exclusion of women undergoing bladder ureteral or bowel resection [ 19 ]. Eight [ 5 , 15 – 17 , 20 – 23 ] studies assessed the intra-operative complications of RAS and LPS surgical procedures: the Risk Ratio (RR) of 1.638, 95% CI [0.552; 4.855] and p  = 0.373, indicated no significant difference between RAS and LPS. The I2 was 23.3%, and test of heterogeneity suggested low statistical heterogeneity ( Fig.  2 ) . Fig. 2 Forest plot for intraoperative complications comparing RAS with LPS Forest plot for intraoperative complications comparing RAS with LPS Eleven [ 5 , 15 – 18 , 20 – 25 ] studies assessed the post-operative complication of RAS and LPS surgical procedures: the Risk Ratio (RR) of 0.952, 95% CI [0.776; 1.169] and p  = 0.642, indicated no significant difference between RAS and LPS. The I2 was 0.0%, and test of heterogeneity suggested low statistical heterogeneity ( Fig.  3 ) . Fig. 3 Forest plot for postoperative complications comparing RAS with LPS Forest plot for postoperative complications comparing RAS with LPS Four [ 5 , 17 , 21 , 23 ] studies assessed the conversion rates of RAS and LPS surgical procedures: the Risk Ratio (RR) of 1.262, 95% CI [0.328; 4.846] and p  = 0.734, indicated no significant difference between RAS and LPS. The I 2 was 0.0%, and the test of heterogeneity suggested low statistical heterogeneity ( Fig.  4 ). Fig. 4 Forest plot for conversion rates comparing RAS with LPS Forest plot for conversion rates comparing RAS with LPS Eleven [ 5 , 14 , 15 , 17 , 20 – 23 , 25 – 27 ] studies assessed the operative time of the two surgical procedures. The standardisation mean difference (SMD) of 0.54 (min), 95% CI [0.247; 0.842] and p  < 0.0001, shows that the patients in the RAS group have a longer operative time than those of the laparoscopic group. The I 2 was 83% and the Cochrane’s Q test significant results ( p  < 0.0001) suggested high statistical heterogeneity between studies ( Fig.  5 ). Fig. 5 Forest plot for operative time comparing RAS with LPS Forest plot for operative time comparing RAS with LPS Nine [ 5 , 14 , 15 , 17 , 20 – 23 , 25 ] studies assessed the estimated blood loss of RAS and LPS surgical procedures: the standardisation mean difference (SMD) of 0.028, 95% CI [− 0.080; 0.136] and p  = 0.616, indicated no significant difference between RAS and LPS. The I 2 was 1.8%, and the test of heterogeneity suggested low statistical heterogeneity ( Fig.  6 ) . Fig. 6 Forest plot for blood loss comparing RAS with LPS Forest plot for blood loss comparing RAS with LPS Seven [ 17 , 20 – 23 , 25 , 26 ] studies assessed hospitalization stay of RAS vs LPS surgical procedures: the standardisation mean difference (SMD) of 0.135, 95% CI [0.022; 0.262] and p  = 0.020, indicated a significant difference between RAS and LPS. The I 2 was 26.7%, and the test of heterogeneity suggested low statistical heterogeneity ( Fig.  7 ). Fig. 7 Forest plot for the length of hospitalization comparing RAS with LPS Forest plot for the length of hospitalization comparing RAS with LPS

Statistical analyses were performed using R statistical software (version 4.2.1) meta e metaplus statistical package of the software R was used. Risk Ratios (RRs) alongside their 95% confidence intervals (CIs) for intra-, postoperative complications and conversion rates data were extracted from the studies or calculated. To continue variables (operative time (min) OT, estimated blood loss (EBL) and hospitalization stay) SMD were calculated. A random-effects model was used to take the source of heterogeneity related to the clinical setting into account. To assess heterogeneity between studies, the Cochrane’s Q test and I 2 index were used. p values of < 0.05 were considered as valid for heterogeneity tests. Pooled estimations and the related 95% CIs were evaluated using forest plots. A funnel plot was depicted for the detection of publication bias.

The risk of bias was assessed independently by two reviewers (MP and AB) using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool [ 13 ]. The risk of bias was assessed for the following domains: patient selection, index test, reference standard, and flow and timing. Discordant assessments were resolved by consultation of a third author (MG).

In conclusion, robotic surgery is not inferior to laparoscopy in patients with endometriosis in terms of surgical outcomes; however, RAS require longer operative times and longer hospital stays. The benefits of robotic surgery should be sought in the easiest potential integration of robotic platforms with new technologies. Furthermore, prospective studies comparing laparoscopy to the new robotic systems are desirable for greater robustness of scientific evidence.

The results of this meta-analysis show the absence of significant differences between the robotic-assisted surgery and the standard laparoscopic approach for endometriosis surgery in terms of intraoperative and postoperative complications, conversion rate and estimated blood loss. However, patients in the RAS group have a longer operative time ( p  < 0.0001) and longer hospital stay ( p  = 0.020) than those in the laparoscopic group. These results confirm what was previously reported in the metanalysis of Restaino et al. comprising 5 articles on the same topic, with no statistical differences for operative outcomes and a longer OT reported for RAS with a weighted mean difference of 0.54 ( p  < 0.00001) [ 9 ]. Therefore, discrepancies are reported in the literature regarding OT in RAS procedures for endometriosis. A longer operating time (MD = 28.09 min, CI 11.59–44.59) and an increased average time of use of the operating room (MD = 51.39 min, CI 15.07–87.72;) is also shown by Csirzó et al. in their recent article [ 28 ]. However, Magrina et al. [ 21 ] after adjusting their findings for age, blood loss, and number of procedures per patient, showed that RAS approach resulted in 16.2% shorter OT than LPS. A recent prospective multicentre randomized trial (LAROSE trial) enrolling 73 patients with suspicion of pelvic endometriosis, showed a similar OT between RAS and LPS (mean ± SD, 107 ± 48 min vs. 102 ± 63 min) when adjusted to the stage of disease [ 5 ]. According to the latter, the study of Raimondo et al. [ 23 ] showed no significant difference between the two groups regarding OT. Among the factors contributing to the extension of the time required to perform robotic surgery is the docking of the platform. However, these times are directly proportional to the team’s experience and decrease with the learning curve [ 29 ]. Regarding the longer hospital stay this could be attributable to a bias in the worst health conditions of patients who are candidates for robotic surgery than for LPS (i.e. obesity) [ 30 ]. In addition, after two decades of the Da Vinci ® surgical robotic system (Intuitive Surgical, California, USA) as the sole protagonist in the field of RAS, the introduction of new robotic platforms on the marketplace with different features (i.e. open consoles, independent bed-side units) may highlight new evidence. The feasibility of surgical interventions for endometriosis using the new HUGO ™ RAS (Medtronic, Minneapolis, USA) [ 31 , 32 ] has already been demonstrated while for other new platforms as the Versius (CMR robotics, UK) system studies are ongoing [ 33 ]. Robotic single-site surgery for managing endometriosis was carried out by Huang et al. In 12% of cases, an extra port was introduced to facilitate greater precision of instruments and to address a broader surgical field, particularly in instances involving more complex locations [ 34 ]. Despite the growing global adoption of robotic surgery and the increased expertise among surgeons, there is currently insufficient evidence to establish the superiority of robotic surgery over standard laparoscopy in endometriosis surgery. The limited reimbursement for robotic procedures and the extended operative time remains significant concerns, particularly when juxtaposed with the absence of discernible differences in perioperative outcomes. It is important to assess the benefits of the development of robotic surgery beyond the comparison of specific outcomes. As the range of available platforms continues to expand, it becomes imperative to precisely delineate the potential advantages and constraints associated with different systems. The crucial task is not solely to choose the most suitable platform for an individual surgeon, but also to pinpoint the optimal system tailored to the specific requirements of single patients or procedures [ 35 ]. The current challenge lies in the training of surgeons and the development of the operating room of the future. In the era of digital surgery, robotic platforms serve as computer interfaces capable of integrating various real-time data analysis modalities. This enables advanced systems to provide augmented surgical vision through augmented reality (AR), improved surgical decisions using artificial intelligence (AI), and enhanced surgical manoeuvres through the advancement of robotic instruments [ 36 ]. The incorporation of preoperative planning, utilizing 3D acquisition of radiological images, coupled with the utilization of deep learning (DL) algorithms to analyze surgical phases, forms an ideal toolkit for enhancing robotic surgery [ 37 ]. This holistic approach aims to reduce intraoperative complications and optimize surgical outcomes by minimizing surgical discrepancies. The operating room is transitioning into a control center akin to an airport control tower, capable of processing 2D/3D inputs derived from preoperative images, environmental and laparoscopic cameras, and patient physiological signals. It then relays outputs to robotic platforms, offering real-time information on the surgeon’s screen during intraoperative processes, such as remaining operating time or the patient’s clinical situation. Image-guided surgery, particularly intraoperative ultrasound, is gaining prominence in robotic surgery [ 38 , 39 ]. The integration of drop-in ultrasound probes, easily manipulated by robotic graspers, allows access to challenging anatomical spaces [ 40 ]. Intraoperative ultrasound, with images projected onto the surgeon’s screen via platforms like Intuitive Surgical’s TilePro, proves beneficial for achieving surgical radicality in endometriosis [ 41 ]. Moreover, robotic systems prove beneficial for educational purposes, providing simulators that can democratize training opportunities, even for non-expert surgeons [ 42 ]. In this context, the recent published IDEAL Robotics Colloquium proposes recommendations for evaluation during development, comparative study and clinical monitoring of surgical robots—providing practical guidelines for developers, clinicians, patients and healthcare systems [ 43 ]. This paper represents the most recent analysis of the current literature on the comparison of RAS and laparoscopy in patients with endometriosis. The inclusion of 5 papers published in the last 24 months, as well as the methodological accuracy and the assessment of the risk of bias are undoubtedly strengths of the work. However, the retrospective nature of most of the included articles and the adoption in all papers of the Da Vinci platform as the only robotic system analysed represent a limitation of this research. Only one prospective trial was found ongoing ( NCT05179109 ) with the aim to examine whether robot-assisted laparoscopy is superior compared to conventional laparoscopy as regards to patient outcome at 6, 12 and 24 months postoperatively, measured by questionnaires concerning the pain symptoms and disease-related quality-of-life. Future studies, including experience with new robotic platforms and comparisons between these, will be needed to better understand the benefits of RAS over conventional laparoscopy.

According to the PICO [ 10 ] schema were selected articles focused on comparison between robotic assisted and laparoscopic surgery in deep endometriosis regarding at least one of the following parameters: (i) intraoperative complications (ii) postoperative complications (iii) operative time (iv) conversion rate (v) estimated blood loss (vi) hospital stay. Articles not reporting comparisons between the two surgical approaches were excluded. Only full-text studies were considered eligible for inclusion. Abstracts, reviews, meta-analyses, letters, case reports and editorials were excluded (Table 1 ). Table 1 Study Characteristics Author Year Study type Group Sample size ( n ) Age (mean, SD) BMI rASRM(12) stage Nezhat et al. [ 14 ] 2010 Retrospective LPS RAS 38 40 33 (18–46) 35 (22–49) 23 (18–31) 24 (19–37) I–IV Dulemba et al. [ 15 ] 2013 Retrospective LPS RAS 100 180 29.2 ± 9.2 32.6 ± 9.7 26.8 ± 11.9 27.9 ± 7.7 I–IV Nezhat et al. [ 20 ] 2014 Retrospective LPS RAS 86 32 40 ± 4.5 42.5 ± 2.2 24.53 ± 1.2 27.36 ± 2.5 III–IV Nezhat et al. [ 19 ] 2015 Retrospective LPS RAS 273 147 31 ± 5.7 30 ± 2.5 23 ± 2.5 23 ± 3.2 III–IV Magrina et al. [ 21 ] 2015 Retrospective LPS RAS 162 331 38.3 ± 10.7 40 ± 10.1 25.5 ± 5.7 26.1 ± 5.9 III–IV Soto et al. [ 5 ] 2017 Prospective LPS RAS 38 35 34.5 ± 8.5 34.3 ± 7.2 24.8 ± 5.9 26.1 ± 5.2 I–IV Le Gac et al. [ 22 ] 2020 Prospective LPS RAS 25 23 37 ± 8 36 ± 7 25 ± 4 25 ± 3 III–IV Hiltunen et al. [ 16 ] 2021 Retrospective LPS RAS 76 18 NA NA 26 (19–39) 24 (18–38) I–IV Raimondo et al. [ 23 ] 2021 Retrospective LPS RAS 22 22 36 ± 5 38 ± 7 22.5 (21–24) 24.5 (21–27) III–IV Ferrier et al. [ 17 ] 2022 Retrospective LPS RAS 61 61 35 ± 7 36 ± 7 26 ± 8 25 ± 5 I–IV Legendri et al. [ 18 ] 2022 Retrospective LPS RAS 28 26 34 (27.5–37.5) 36.5(29.7–43.5) 23 (21–29) 23 (20.5–27.5) IV Crestani et al. [ 26 ] 2023 Retrospective LPS RAS 73 89 NA NA 26 (19–39) 24 (18–38) III–IV Volodarsky Perel et al. [ 24 ] 2023 Retrospective LPS RAS 451 97 37.9 (31.7–44.1 37.3 (30.5–44.1) 22.6 (20.3–25.6) 23.2 (21.3–26.9) III–IV Verrelli et al. [ 25 ] 2023 Retrospective LPS RAS 104 71 38.4 (31.5–45.3) 37.3 (31.4–43.2) 23.6 (19.5–27.7) 23.8 (18.8–28.8) III–IV Study Characteristics LPS RAS 38 40 33 (18–46) 35 (22–49) 23 (18–31) 24 (19–37) LPS RAS 100 180 29.2 ± 9.2 32.6 ± 9.7 26.8 ± 11.9 27.9 ± 7.7 LPS RAS 86 32 40 ± 4.5 42.5 ± 2.2 24.53 ± 1.2 27.36 ± 2.5 LPS RAS 273 147 31 ± 5.7 30 ± 2.5 23 ± 2.5 23 ± 3.2 LPS RAS 162 331 38.3 ± 10.7 40 ± 10.1 25.5 ± 5.7 26.1 ± 5.9 LPS RAS 38 35 34.5 ± 8.5 34.3 ± 7.2 24.8 ± 5.9 26.1 ± 5.2 LPS RAS 25 23 37 ± 8 36 ± 7 25 ± 4 25 ± 3 LPS RAS 76 18 NA NA 26 (19–39) 24 (18–38) LPS RAS 22 22 36 ± 5 38 ± 7 22.5 (21–24) 24.5 (21–27) LPS RAS 61 61 35 ± 7 36 ± 7 26 ± 8 25 ± 5 LPS RAS 28 26 34 (27.5–37.5) 36.5(29.7–43.5) 23 (21–29) 23 (20.5–27.5) LPS RAS 73 89 NA NA 26 (19–39) 24 (18–38) LPS RAS 451 97 37.9 (31.7–44.1 37.3 (30.5–44.1) 22.6 (20.3–25.6) 23.2 (21.3–26.9) LPS RAS 104 71 38.4 (31.5–45.3) 37.3 (31.4–43.2) 23.6 (19.5–27.7) 23.8 (18.8–28.8)

Endometriosis, is an “onco-mimetic” inflammatory disease influenced by estrogen, that impacts the 10–15% of women in their reproductive age [ 1 ]. It primarily presents in the pelvic region, manifesting as superficial peritoneal implants, ovarian endometriomas, or “deep” lesions extending beyond the peritoneal surface (> 5 mm), commonly found in areas like the uterosacral ligaments, rectouterine pouch, vagina, bowel, bladder, and ureters. Symptoms vary based on the location and may include dysmenorrhea, chronic pelvic pain, dyspareunia, infertility, and urinary and intestinal function impairment [ 2 ]. Surgical excision of lesions is considered recommended if hormonal treatments prove insufficient to manage the symptoms [ 3 , 4 ], in case of bowel or ureteral stricture or in selective case of infertility [ 4 ]. Minimally invasive surgical (MIS) approaches have become predominant in the surgical management of the disease, with laparoscopy as a standard of care [ 4 ]. Despite its advantages, conventional laparoscopy has limitations such as 2-dimensional visualization, ergonomic limits, and a restricted range of instruments. Over the past decade, the viability, efficacy, and safety of robotic-assisted surgery (RAS) in addressing deep endometriosis has been reported, demonstrating its non-inferiority to laparoscopy [ 5 ]. Robotic systems offer enhanced depth perception, wrist articulation, and dexterity, particularly beneficial for complex cases or challenging anatomical locations like diaphragmatic endometriosis or sites involving the sacral plexus or ischial nerves [ 6 , 7 ]. The use of robotic articulated instruments, equipped with clutching mechanisms that exceed the range of motion of the human wrist (> 360°), facilitates access to these areas. However, the lack of tactile feedback and the associated high costs of installation and maintenance present obstacles to the widespread adoption of RAS [ 8 ]. Despite established benefits in various surgical domains, the superiority of RAS over traditional laparoscopy in treating endometriosis remains unknown [ 9 ]. The aim of this meta-analysis is to compare the effectiveness and safety of these approaches in the surgical management of endometriosis.

Below is the link to the electronic supplementary material. Supplementary file1 (DOCX 15 KB) Supplementary file2 (DOCX 19 KB) Supplementary file3 (DOCX 23 KB) Supplementary file4 (DOCX 77 KB) Supplementary file1 (DOCX 15 KB) Supplementary file2 (DOCX 19 KB) Supplementary file3 (DOCX 23 KB) Supplementary file4 (DOCX 77 KB)